Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Antipsychotic use and mortality risk in community-dwelling Alzheimer's disease patients: evidence for a role of dementia severity.

Gardette V, Lapeyre-Mestre M, Coley N, Cantet C, Montastruc JL, Vellas B, Andrieu S.

Curr Alzheimer Res. 2012 Nov;9(9):1106-16.

PMID:
22950915
2.

Antipsychotic polypharmacy among a nationwide sample of community-dwelling persons with Alzheimer's disease.

Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S.

J Alzheimers Dis. 2014;41(4):1223-8. doi: 10.3233/JAD-140282.

PMID:
24787914
3.

Predictors of mortality in atypical antipsychotic-treated community-dwelling elderly patients with behavioural and psychological symptoms of dementia: a prospective population-based cohort study from Italy.

Rafaniello C, Lombardo F, Ferrajolo C, Sportiello L, Parretta E, Formica R, Potenza S, Rinaldi B, Irpino A, Raschetti R, Vanacore N, Rossi F, Capuano A.

Eur J Clin Pharmacol. 2014 Feb;70(2):187-95. doi: 10.1007/s00228-013-1588-3.

PMID:
24145814
4.
5.

The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial.

Ballard C, Hanney ML, Theodoulou M, Douglas S, McShane R, Kossakowski K, Gill R, Juszczak E, Yu LM, Jacoby R; DART-AD investigators..

Lancet Neurol. 2009 Feb;8(2):151-7. doi: 10.1016/S1474-4422(08)70295-3.

PMID:
19138567
6.

The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.

Katz I, de Deyn PP, Mintzer J, Greenspan A, Zhu Y, Brodaty H.

Int J Geriatr Psychiatry. 2007 May;22(5):475-84.

PMID:
17471598
7.

Association between prescription of conventional or atypical antipsychotic drugs and mortality in older persons with Alzheimer's disease.

Musicco M, Palmer K, Russo A, Caltagirone C, Adorni F, Pettenati C, Bisanti L.

Dement Geriatr Cogn Disord. 2011;31(3):218-24. doi: 10.1159/000326213.

8.

Antipsychotic drug use and mortality in older adults with dementia.

Gill SS, Bronskill SE, Normand SL, Anderson GM, Sykora K, Lam K, Bell CM, Lee PE, Fischer HD, Herrmann N, Gurwitz JH, Rochon PA.

Ann Intern Med. 2007 Jun 5;146(11):775-86.

PMID:
17548409
9.

Antipsychotics and cognitive decline in Alzheimer's disease: the LASER-Alzheimer's disease longitudinal study.

Livingston G, Walker AE, Katona CL, Cooper C.

J Neurol Neurosurg Psychiatry. 2007 Jan;78(1):25-9.

10.

Short- and long-term mortality risk associated with the use of antipsychotics among 26,940 dementia outpatients: a population-based study.

Langballe EM, Engdahl B, Nordeng H, Ballard C, Aarsland D, Selbæk G.

Am J Geriatr Psychiatry. 2014 Apr;22(4):321-31. doi: 10.1016/j.jagp.2013.06.007.

PMID:
24016844
11.

Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease.

Lopez OL, Wisniewski SR, Becker JT, Boller F, DeKosky ST.

Arch Neurol. 1999 Oct;56(10):1266-72.

PMID:
10520944
12.

Mortality in elderly dementia patients treated with risperidone.

Haupt M, Cruz-Jentoft A, Jeste D.

J Clin Psychopharmacol. 2006 Dec;26(6):566-70.

PMID:
17110812
13.

Risk of cerebrovascular adverse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study.

Mehta S, Johnson ML, Chen H, Aparasu RR.

J Clin Psychiatry. 2010 Jun;71(6):689-98. doi: 10.4088/JCP.09m05817yel.

PMID:
20573328
14.

Behavioral and psychological symptoms assessed with the BEHAVE-AD-FW are differentially associated with cognitive dysfunction in Alzheimer's disease.

Ito T, Meguro K, Akanuma K, Meguro M, Lee E, Kasuya M, Ishii H, Mori E.

J Clin Neurosci. 2007 Sep;14(9):850-5.

PMID:
17587584
15.

Dementia-associated mortality at thirteen years in the NEDICES Cohort Study.

Villarejo A, Benito-León J, Trincado R, Posada IJ, Puertas-Martín V, Boix R, Medrano MR, Bermejo-Pareja F.

J Alzheimers Dis. 2011;26(3):543-51. doi: 10.3233/JAD-2011-110443.

PMID:
21694455
16.

Effect of comorbidity on the risk of death associated with antipsychotic use among community-dwelling older adults.

Gisev N, Hartikainen S, Chen TF, Korhonen M, Bell JS.

Int Psychogeriatr. 2012 Jul;24(7):1058-64. doi: 10.1017/S1041610212000117.

PMID:
22364618
17.

Treated Behavioral Symptoms and Mortality in Medicare Beneficiaries in Nursing Homes with Alzheimer's Disease and Related Dementias.

Huang TY, Wei YJ, Moyo P, Harris I, Lucas JA, Simoni-Wastila L.

J Am Geriatr Soc. 2015 Sep;63(9):1757-65. doi: 10.1111/jgs.13606.

PMID:
26310959
18.

Adverse events in elderly users of antipsychotic pharmacotherapy in the province of Manitoba: a retrospective cohort study.

Vasilyeva I, Biscontri RG, Enns MW, Metge CJ, Alessi-Severini S.

J Clin Psychopharmacol. 2013 Feb;33(1):24-30. doi: 10.1097/JCP.0b013e31827934a4.

PMID:
23277238
19.

Is donepezil therapy associated with reduced mortality in nursing home residents with dementia?

Gasper MC, Ott BR, Lapane KL.

Am J Geriatr Pharmacother. 2005 Mar;3(1):1-7.

PMID:
16089241
20.

Use and misuse of antipsychotic drugs in patients with dementia in Alzheimer special care units.

Nobili A, Pasina L, Trevisan S, Riva E, Lucca U, Tettamanti M, Matucci M, Tarantola M.

Int Clin Psychopharmacol. 2009 Mar;24(2):97-104.

PMID:
21456106
Items per page

Supplemental Content

Support Center